Hepavax-B

Hepatitis B Vaccine [rDNA] ·Popular Pharmaceuticals PLC·IM Injection

0 views 0 reviews

Administration

Neonates, infants and children upto 19 years of age: The recommended dose of Hepatitis B vaccine (rDNA) is >10 mcg of antigen protein in 0.5 ml.

Adults 19 years of age and older: The recommended dose of Hepatitis B vaccine (rDNA) is >20 mcg of antigen in 1 ml.

Primary immunization schedule for all ages:
The usual immunization schedule consists of 3 doses of vaccine-

First dose: at elected date
Second dose: 1 month after first dose
Third dose: 6 months after first dose

or accelerated schedule consists of 4 doses of vaccine-

First dose: at elected date
Second dose: 1 month after first dose
Third dose: 2 months after first dose
Fourth dose: 12 months after first dose

Accelerated schedule confer protection more quickly and is expected to provide better patient compliance.

Neonate born to hepatitis B surface antigen-positive mother, 4 doses of 10 micrograms:

First dose: at birth with Hepatitis B immunoglobulin injection (separate site)
Second dose: 1 month after first dose
Third dose: 2 months after first dose
Fourth dose: 12 months after first dose

For travellers departing within 1 month, adult over 18 years,

First dose: at elected date
Second dose: 7 days after first dose
Third dose: 21 days after first dose
Fourth dose: 12 months after first dose

Renal insufficiency (including haemodialysis patients), adult and child over 16 years 4 doses of 40 micrograms-

First dose: at the appropriate date
Second dose: 1 month after first dose
Third dose: 2 months after first dose
Fourth dose: 6 months after first dose

Immunization schedule and booster doses may need to be adjusted in those with low antibody concentration.

Booster vaccinations: For persons with normal immune status who have been vaccinated, booster doses of
Hepatitis B vaccine has not been established. However, booster doses are recommended for hemodialysis patients or other immunocompromised persons.

Effects

Hepatitis B vaccine is generally well tolerated. Most recipients of Hepatitis B vaccine experience some reactions upon vaccination. These are generally moderate and short. They mainly consist of local reactions at the injection site (erythema, induration and tenderness). Systemic reactions (malaise, headache, diarrhea, vomiting, myalgia and elevated temperature) are reported less commonly. In very rare cases allergic type reactions (pruritus, rash, urticaria) may be observed.

Indications

Hepatitis B Vaccine is indicated for active immunization against infection caused by all known subtypes of Hepatitis B virus. As Hepatitis D (caused by the delta virus) does not occur in the absence of Hepatitis B infection, it can be expected that Hepatitis D will also be prevented by Hepatitis B vaccination.

Immunization is recommended in persons of all ages, especially those who are, or will be, at increased risk of exposure to Hepatitis B virus, for example:

A baby whose mother is infected can be infected at birth.
Children, adolescents, and adults can become infected by:

Contact with blood and body fluids through breaks in the skin such as bites, cuts, or sores
Contact with objects that have blood or body fluids on them such as toothbrushes, razors or monitoring and treatment devices for diabetes
Having unprotected sex with an infected person
Sharing needles when injecting drugs
Being stuck with a used needle
Household contacts of people infected with Hepatitis B
Residents and staff in institutions for the developmental^ disabled
Kidney dialysis patients
People who travel to countries where Hepatitis B is common
People with HIV infection
Persons with hemophilia, thalassemia, sickle cell anemia, cirrhosis

Military personnel identified as being at increased risk.
Morticians and Embalmers.
Prisoners.
Users of illicit injectable drugs.
Others: Police, fire department personnel, who render first aid or medical assistance, and any others who, through their work or personal life-style, may be exposed to the Hepatitis B virus.